Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
$877K Buy
34,602
+6,535
+23% +$171K 0.08% 125
2024
Q4
$745K Sell
28,067
-7,468
-21% -$203K 0.06% 145
2024
Q3
$1.03M Sell
35,535
-1,938
-5% -$56.5K 0.1% 107
2024
Q2
$1.05M Buy
37,473
+208
+0.6% +$5.73K 0.11% 98
2024
Q1
$1.03M Buy
37,265
+3,926
+12% +$109K 0.1% 100
2023
Q4
$960K Sell
33,339
-5,680
-15% -$172K 0.1% 99
2023
Q3
$1.29M Buy
39,019
+4,713
+14% +$167K 0.16% 72
2023
Q2
$1.26M Sell
34,306
-535
-2% -$20.8K 0.15% 76
2023
Q1
$1.42M Sell
34,841
-335
-1% -$14.5K 0.18% 66
2022
Q4
$1.8M Buy
35,176
+562
+2% +$26.9K 0.24% 47
2022
Q3
$1.51M Buy
34,614
+1,095
+3% +$53.2K 0.23% 52
2022
Q2
$1.76M Buy
33,519
+1,032
+3% +$52.6K 0.26% 44
2022
Q1
$1.68M Buy
32,487
+789
+2% +$40.9K 0.23% 59
2021
Q4
$1.87M Sell
31,698
-7,788
-20% -$386K 0.26% 49
2021
Q3
$1.7M Sell
39,486
-4,759
-11% -$211K 0.27% 51
2021
Q2
$1.73M Buy
44,245
+261
+0.6% +$10.2K 0.28% 41
2021
Q1
$1.59M Buy
43,984
+18,092
+70% +$642K 0.26% 46
2020
Q4
$953K Buy
25,892
+7,658
+42% +$281K 0.22% 39
2020
Q3
$635K Buy
18,234
+1,050
+6% +$36.8K 0.19% 41
2020
Q2
$533K Buy
17,184
+264
+2% +$8.97K 0.16% 49
2020
Q1
$524K Sell
16,920
-940
-5% -$32K 0.2% 36
2019
Q4
$664K Buy
+17,860
New +$636K 0.25% 37

Other funds holding PFE

Marcum Wealth's PFE Position: Q1 2025 in Review

Marcum Wealth increased its Pfizer (PFE) stake by 23% in Q1 2025, buying an estimated $171K and bringing the position to 34,602 shares worth $877K. The position accounts for 0.08% of the portfolio, ranked #125.

Marcum Wealth first reported a position in PFE in Q4 2019 and has held it in 22 quarters since. The position peaked at $1.87M in Q4 2021. 2,931 funds tracked by Wall St. Rank hold PFE as of Q1 2025.

  • Marcum Wealth held 34,602 shares of Pfizer worth $877K as of Q1 2025.
  • Marcum Wealth bought 6,535 Pfizer shares in Q1 2025, an estimated $171K.
  • Pfizer made up 0.08% of Marcum Wealth's portfolio in Q1 2025, its #125 holding.
  • Marcum Wealth first reported a position in Pfizer in Q4 2019 and has held it in 22 quarters since.
  • Marcum Wealth's Pfizer position peaked at $1.87M in Q4 2021.
  • 2,931 funds tracked by Wall St. Rank held Pfizer as of Q1 2025.

Based on Marcum Wealth's 13F filing for Q1 2025, filed 2 Apr 2025.